封面
市场调查报告书
商品编码
1691702

猪疫苗市场 - 全球产业规模、份额、趋势、机会和预测,按产品、类型、目标疾病、地区和竞争细分,2020-2030 年预测

Swine Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Type, By Target Disease, By Region & Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球猪疫苗市场价值为 13.2 亿美元,预计在预测期内将实现令人印象深刻的成长,到 2030 年的复合年增长率为 4.85%。全球猪疫苗市场是动物保健产业的重要领域,专注于预防和管理猪群疾病。猪疫苗对于确保养猪业中猪的健康和生产力起着至关重要的作用,而养猪业是全球肉类产业的重要组成部分。例如,根据《世界人口评论》的《2024年猪肉消费数据》,全球猪肉消费量为112.6万吨,预计到2031年将增加至129万吨。这种不断增长的需求,尤其是在亚太地区、欧洲和北美,凸显了对健康高产猪群的需求。为了维持供应和质量,养猪生产商优先透过有效的疫苗接种来预防疾病,并采用先进的生物安全措施来提高猪群的健康和效率,从而推动市场成长。

市场概况
预测期 2026-2030
2024 年市场规模 13.2 亿美元
2030 年市场规模 17.4 亿美元
2025-2030 年复合年增长率 4.85%
成长最快的领域 重组疫苗
最大的市场 亚太地区

主要市场驱动因素

猪肉需求不断成长

主要市场挑战

新兴疾病和病原体

主要市场趋势

精准疫苗接种

目录

第 1 章:产品概述

第 2 章:研究方法

第 3 章:执行摘要

第 4 章:顾客之声

第五章:全球猪疫苗市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 副产品(减毒活疫苗、DNA疫苗、灭活疫苗、重组疫苗、次单位疫苗)
    • 依类型(胸膜肺炎放线桿菌、猪瘟、口蹄疫、PEDV、猪圆环病毒 2 型、猪细小病毒、PRRS、伪狂犬病、猪流感)
    • 依目标疾病(关节炎、百日咳鼻炎、腹泻、口蹄疫、猪圆环病毒相关疾病、猪生殖与呼吸症候群、伪狂犬病、猪流感)
    • 按地区
    • 按公司分类(2024)
  • 产品市场图
    • 按产品
    • 按类型
    • 按目标疾病
    • 按地区

第六章:北美猪疫苗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美:国家分析
    • 加拿大
    • 墨西哥

第七章:欧洲猪疫苗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲:国家分析
    • 英国
    • 法国
    • 义大利
    • 西班牙

第 8 章:亚太猪疫苗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区:国家分析
    • 日本
    • 印度
    • 澳洲
    • 韩国

第九章:南美猪疫苗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲:国家分析
    • 阿根廷
    • 哥伦比亚

第 10 章:中东和非洲猪疫苗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA:国家分析
    • 沙乌地阿拉伯
    • 阿联酋
    • 科威特

第 11 章:市场动态

  • 驱动程式
  • 挑战

第 12 章:市场趋势与发展

  • 近期发展
  • 合併与收购
  • 产品发布

第 13 章:波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 14 章:竞争格局

  • Merck & Co Inc
  • Zoetis Inc
  • Boehringer Ingelheim GmbH
  • Elanco Animal Health Inc
  • Indian Immunologicals Ltd
  • Biogenesis Bago SA
  • Phibro Animal Health Corp
  • Laboratorios HIPRA SA
  • Virbac SA

第 15 章:策略建议

第16章调查会社について・免责事项

简介目录
Product Code: 18799

Global Swine Vaccines Market was valued at USD 1.32 billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 4.85% through 2030. The global swine vaccines market is a vital segment of the animal health industry that focuses on preventing and managing diseases in swine populations. Swine vaccines play a crucial role in ensuring the health and productivity of pigs in the swine farming sector, which is a significant component of the global meat industry. For instance, according to the World Population Review's Pork Consumption Data 2024, global pork consumption stands at 112.6 kilotons and is expected to rise to 129 kilotons by 2031. This increasing demand, especially in Asia-Pacific, Europe, and North America, underscores the need for healthy and productive swine herds. To sustain supply and quality, pig producers are prioritizing disease prevention through effective vaccination, driving market growth as they adopt advanced biosecurity measures to enhance herd health and efficiency.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.32 Billion
Market Size 2030USD 1.74 Billion
CAGR 2025-20304.85%
Fastest Growing SegmentRecombinant Vaccines
Largest MarketAsia Pacific

Key Market Drivers

Rising Demand for Pork

The world's population is steadily increasing, and with it, the demand for protein-rich foods like pork is on the rise. As more people move to urban areas, their dietary preferences tend to shift towards meat-based diets. This urbanization trend amplifies the demand for pork products, leading to larger swine farming operations. To meet this burgeoning demand, farmers rely on swine vaccines to ensure the health and productivity of their herds.

Emerging markets in regions such as Asia, Latin America, and Africa are witnessing a rapid expansion of their middle-class populations. As incomes rise, so does the consumption of animal protein, including pork. This socio-economic shift is a major driver of increased demand for pork and, consequently, for swine vaccines. To meet the quality and safety standards demanded by this growing middle-class consumer base, swine farmers invest in disease prevention through vaccination.

Food security is a pressing concern in a world that needs to feed a growing population sustainably. Pork is an efficient source of protein, as pigs can convert feed into meat relatively quickly compared to other livestock. Ensuring the health and well-being of swine herds through vaccination is a key component of sustainable swine farming. Healthy pigs mean higher yields, reduced waste, and a more sustainable food supply chain.

Key Market Challenges

Emerging Diseases and Pathogens

The swine industry faces an ongoing threat from emerging diseases and evolving strains of existing pathogens. New diseases, such as African swine fever (ASF) and novel strains of influenza, can have devastating consequences for swine herds. Developing effective vaccines to combat these emerging threats is a constant challenge for vaccine manufacturers.

Key Market Trends

Precision Vaccination

One of the emerging trends in the swine vaccines market is precision vaccination. Traditional vaccines provide broad protection against a range of pathogens, but advances in vaccine technology now allow for more precise targeting of specific diseases. This trend helps swine farmers address unique disease challenges and reduce the potential for adverse reactions.

Key Market Players

  • Merck & Co Inc
  • Zoetis Inc
  • Boehringer Ingelheim GmbH
  • Elanco Animal Health Inc
  • Indian Immunologicals Ltd
  • Biogenesis Bago SA
  • Phibro Animal Health Corp
  • Laboratorios HIPRA SA
  • Virbac SA

Report Scope:

In this report, the Global Swine Vaccines Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Swine Vaccines Market, By Product:

  • Attenuated Live Vaccines
  • DNA Vaccines
  • Inactivated Vaccines
  • Recombinant Vaccines
  • Subunit Vaccines

Swine Vaccines Market, By Type:

  • Actinobacillus Pleuropneumoniae
  • Classical Swine Fever
  • Foot & Mouth Disease
  • PEDV
  • Porcine Circovirus Type 2
  • Porcine Parvovirus
  • PRRS
  • Pseudorabies
  • Swine Influenza

Swine Vaccines Market, By Target Disease:

  • Arthritis
  • Bordetella Rhinitis
  • Diarrhea
  • Foot & Mouth Disease
  • Porcine Circovirus Associated Disease
  • Porcine Reproductive & Respiratory Syndrome
  • Pseudorabies
  • Swine Influenza

Swine Vaccines Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Swine Vaccines Market.

Available Customizations:

Global Swine Vaccines market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Swine Vaccines Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines)
    • 5.2.2. By Type (Actinobacillus Pleuropneumoniae, Classical Swine Fever, Foot & Mouth Disease, PEDV, Porcine Circovirus Type 2, Porcine Parvovirus, PRRS, Pseudorabies, Swine Influenza)
    • 5.2.3. By Target Disease (Arthritis, Bordetella Rhinitis, Diarrhea, Foot & Mouth Disease, Porcine Circovirus Associated Disease, Porcine Reproductive & Respiratory Syndrome, Pseudorabies, Swine Influenza)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Product Market Map
    • 5.3.1. By Product
    • 5.3.2. By Type
    • 5.3.3. By Target Disease
    • 5.3.4. By Region

6. North America Swine Vaccines Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines)
    • 6.2.2. By Type (Actinobacillus Pleuropneumoniae, Classical Swine Fever, Foot & Mouth Disease, PEDV, Porcine Circovirus Type 2, Porcine Parvovirus, PRRS, Pseudorabies, Swine Influenza)
    • 6.2.3. By Target Disease (Arthritis, Bordetella Rhinitis, Diarrhea, Foot & Mouth Disease, Porcine Circovirus Associated Disease, Porcine Reproductive & Respiratory Syndrome, Pseudorabies, Swine Influenza)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Swine Vaccines Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Type
        • 6.3.1.2.3. By Target Disease
    • 6.3.2. Canada Swine Vaccines Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Type
        • 6.3.2.2.3. By Target Disease
    • 6.3.3. Mexico Swine Vaccines Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Type
        • 6.3.3.2.3. By Target Disease

7. Europe Swine Vaccines Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines)
    • 7.2.2. By Type (Actinobacillus Pleuropneumoniae, Classical Swine Fever, Foot & Mouth Disease, PEDV, Porcine Circovirus Type 2, Porcine Parvovirus, PRRS, Pseudorabies, Swine Influenza)
    • 7.2.3. By Target Disease (Arthritis, Bordetella Rhinitis, Diarrhea, Foot & Mouth Disease, Porcine Circovirus Associated Disease, Porcine Reproductive & Respiratory Syndrome, Pseudorabies, Swine Influenza)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Swine Vaccines Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Target Disease
    • 7.3.2. United Kingdom Swine Vaccines Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Target Disease
    • 7.3.3. France Swine Vaccines Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Target Disease
    • 7.3.4. Italy Swine Vaccines Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Type
        • 7.3.4.2.3. By Target Disease
    • 7.3.5. Spain Swine Vaccines Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Type
        • 7.3.5.2.3. By Target Disease

8. Asia-Pacific Swine Vaccines Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines)
    • 8.2.2. By Type (Actinobacillus Pleuropneumoniae, Classical Swine Fever, Foot & Mouth Disease, PEDV, Porcine Circovirus Type 2, Porcine Parvovirus, PRRS, Pseudorabies, Swine Influenza)
    • 8.2.3. By Target Disease (Arthritis, Bordetella Rhinitis, Diarrhea, Foot & Mouth Disease, Porcine Circovirus Associated Disease, Porcine Reproductive & Respiratory Syndrome, Pseudorabies, Swine Influenza)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Swine Vaccines Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Target Disease
    • 8.3.2. Japan Swine Vaccines Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Target Disease
    • 8.3.3. India Swine Vaccines Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Target Disease
    • 8.3.4. Australia Swine Vaccines Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By Target Disease
    • 8.3.5. South Korea Swine Vaccines Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By Target Disease

9. South America Swine Vaccines Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines)
    • 9.2.2. By Type (Actinobacillus Pleuropneumoniae, Classical Swine Fever, Foot & Mouth Disease, PEDV, Porcine Circovirus Type 2, Porcine Parvovirus, PRRS, Pseudorabies, Swine Influenza)
    • 9.2.3. By Target Disease (Arthritis, Bordetella Rhinitis, Diarrhea, Foot & Mouth Disease, Porcine Circovirus Associated Disease, Porcine Reproductive & Respiratory Syndrome, Pseudorabies, Swine Influenza)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Swine Vaccines Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Target Disease
    • 9.3.2. Argentina Swine Vaccines Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Target Disease
    • 9.3.3. Colombia Swine Vaccines Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Target Disease

10. Middle East and Africa Swine Vaccines Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines)
    • 10.2.2. By Type (Actinobacillus Pleuropneumoniae, Classical Swine Fever, Foot & Mouth Disease, PEDV, Porcine Circovirus Type 2, Porcine Parvovirus, PRRS, Pseudorabies, Swine Influenza)
    • 10.2.3. By Target Disease (Arthritis, Bordetella Rhinitis, Diarrhea, Foot & Mouth Disease, Porcine Circovirus Associated Disease, Porcine Reproductive & Respiratory Syndrome, Pseudorabies, Swine Influenza)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Swine Vaccines Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By Target Disease
    • 10.3.2. Saudi Arabia Swine Vaccines Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By Target Disease
    • 10.3.3. UAE Swine Vaccines Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By Target Disease
    • 10.3.4. Kuwait Swine Vaccines Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Product
        • 10.3.4.2.2. By Type
        • 10.3.4.2.3. By Target Disease

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Merck & Co Inc
    • 14.1.1. Business Overview
    • 14.1.2. Product Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. Zoetis Inc
  • 14.3. Boehringer Ingelheim GmbH
  • 14.4. Elanco Animal Health Inc
  • 14.5. Indian Immunologicals Ltd
  • 14.6. Biogenesis Bago SA
  • 14.7. Phibro Animal Health Corp
  • 14.8. Laboratorios HIPRA SA
  • 14.9. Virbac SA

15. Strategic Recommendations

16. About Us & Disclaimer